Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 10 Jun 2021 for AbCellera Biologics Inc., €20.9M. Read the official filing
Filing timeline
BuySaleTryn Stimart
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Tryn Stimart: trading record in brief
Tryn Stimart is a declared insider of AbCellera Biologics Inc. (senior executive), with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated from 7 June 2021 to 9 June 2021.
Every open-market trade on record is a sale: 1 sale worth €20.9M. Outside the open market, there are 1 option exercise.
The record was last updated on 10 June 2021 with an open-market sale (€20.9M) in AbCellera Biologics Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Tryn Stimart
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
1,000,000 shares@ US$25.5099.1% of flowCommon SharesSEC:0000899243-21-022989:0
750,000 shares@ US$0.320.9% of flowCommon SharesSEC:0000899243-21-022899:0
2 of 2 declarations
